AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccine proves protective in preliminary studies.(sepsis)

Vaccine Weekly

| December 11, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A group of researchers from the Scripps Research Institute (TSRI) have designed a vaccine that might be used to protect against the pernicious consequences of severe sepsis, an acute and often deadly disease that is estimated to strike 700,000 Americans a year and millions more worldwide.

Though the new vaccine has not yet been applied to clinical trials in humans, it has worked well in preclinical studies, the results of which the team reported in Angewandte Chemie.

"The vaccine provided outstanding protection," said author Kim Janda, PhD, who holds the Ely R. Callaway, Jr. Chair in Chemistry at TSRI.

Sepsis, also known as septic shock and systemic inflammatory response syndrome, is characterized by shock to one's organs following poisoning with endotoxins - chemical components of certain bacteria. The endotoxin molecules themselves are not particularly harmful, but the way that the immune system reacts to them is.

When bacteria like the deadly N. meningitides invade the body, they trigger the immune system to stage a biochemical defense. One of the ways that the body initially responds to such an infection is to recruit white blood cells, like macrophages, which engulf the pathogens and destroy them. The macrophages also fight the pathogens by producing chemicals at the site of an infection that induce inflammation.

However, there is a limit to how much inflammation a body can take. If the infection is widespread, the systemic endotoxin levels can be so high that the macrophages respond by producing a lethal amount of inflammatory chemicals. One of these chemicals is called tumor necrosis factor alpha (TNF-alpha).

The prognosis for sepsis is dire. It can affect many parts of the body, from the bones to the brain, and death due to septic shock can occur in a matter of hours. According to the National Institutes of Health, 2% of all hospital admissions suffer from sepsis, and its typical case-fatality rate is around 30%. According to the Centers for Disease Control and Prevention, sepsis is one of the 10 leading causes of both infant and adult mortality in the United States, and, in 1999, directly caused more than 30,000 deaths.

Related articles from newspapers, magazines, journals, and more
A Passion For Publishing: Peter Golitz Celebrates 25 Years as Editor-in-Chief...
Press release article from: M2 Presswire November 1, 2007 700+ words
...25 Years as Editor-in-Chief of Angewandte Chemie(C)1994-2007 M2 COMMUNICATIONS...German Chemical Society's journal "Angewandte Chemie" at Verlag Chemie publishers in...has been instrumental in developing Angewandte Chemie, or Angewandte as it is known colloquially...
Researchers at the University of California, Davis, US, have developed a new...
Magazine article from: Chemistry and Industry August 25, 2008 700+ words
...California, Davis, US, have developed a new method for the direct conversion of cellulose into furan-based biofuels (Angewandte Chemie International, doi: 10.1002/anie.200801594). The process avoids both the breaking down of the cellulose and subsequent...
Neovacs Announces the Publication of a PNAS Article on Anti-IFN Kinoid Active...
Press release article from: Business Wire March 16, 2009 700+ words
...Suggest That IFN-Kinoid-Based Active Immunization May Represent a Safe and Effective...an article on anti-IFN kinoid active immunization in the March 11th edition of the...efficacy of an anti-IFN kinoid active immunization approach in a mouse model of systemic...
ImClone Presents Data On Active Immunization Against FLK-1 Protein to Inhibit...
Press release article from: Business Wire April 5, 2000 700+ words
...whether the effect of eliciting an immune response by active immunization against the FLK-1 receptor in mice could lead to inhibition...against FLK-1 became tumor free. These data suggest that active immunization against angiogenesis-related targets may be a potentially...
Vaccine proves protective in preliminary studies.
Newspaper article from: Medical Letter on the CDC & FDA December 15, 2002 700+ words
...sought to use active immunization to protect patients against sepsis. Active immunization, used in measles...MT, et al., Active immunization with a glycolipid...endotoxic shock. Angewandte Chemie, November 18...
Sepsis Vaccine Proves Protective in Preliminary Studies by Scientists at The...
News wire article from: Ascribe Higher Education News Service November 13, 2002 700+ words
...of the journal Angewandte Chemie. "The vaccine...sought to use active immunization to protect patients against sepsis. Active immunization, used in measles...The article, "Active Immunization with a Glycolipid...
Guardians of Science: Fairness and Reliability of Peer Review.
Magazine article from: Chemistry and Industry Ross, Paul F. April 4, 1994 700+ words
...of the peer review process at Angewandte Chemie', then just published. Peter Golitz, editor at Angewandte -- Chemie, had concurred in an examination...manuscripts received and published in Angewandte Chemie in 1984 and 88 manuscripts rejected...
Beckmann, Ernest Otto
Dictionary definition from: Complete Dictionary of Scientific Biography January 1, 2008 700+ words
...Das Laboratorium f ü r angewandte Chemie der Universit ä t Leipzig...x201D; in Zeitschrift f ü r angewandte Chemie , 26 (1923), 344; C. Paal...x201D; in Zeitschrifi f ü r angewandte Chemie , 26 (1923), 344 – 345...
For more facts and information, see all results

Source: HighBeam Research, Vaccine proves protective in preliminary studies.(sepsis)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA